ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, D. R.
Right arrow Articles by Murray, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, D. R.
Right arrow Articles by Murray, G. F.

The Annals of Thoracic Surgery, Vol 56, 566-568, Copyright © 1993 by The Society of Thoracic Surgeons

ARTICLES

Use of heparin-coated cardiopulmonary bypass

DR Jones, RC Hill, MJ Hollingsed, E Stullken, GM Graeber, RA Gustafson and GF Murray
Department of Surgery, West Virginia University School of Medicine, Morgantown.

A 49-year-old man with unstable angina and a history of severe anaphylaxis to seafood and intravenous iodine needed myocardial revascularization. Because of concern of an intraoperative protamine reaction, preoperative treatment was instituted with steroids and with H1 and H2 blockers. Revascularization was accomplished using a heparin- coated cardiopulmonary bypass circuit. Complement activation and postoperative bleeding were minimal. Heparin-coated cardiopulmonary bypass is a safe, effective technique of bypass in select patients.


This article has been cited by other articles:


Home page
 PerfusionHome page
J. P. Gott
Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation
Perfusion, January 1, 2001; 16(1_suppl): 5 - 9.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al.
ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. P. Gott, W. A. Cooper, F. E. Schmidt Jr, W. M. Brown III, C. E. Wright, J. D. Merlino, J. D. Fortenberry, W. S. Clark, and R. A. Guyton
Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies
Ann. Thorac. Surg., September 1, 1998; 66(3): 747 - 754.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
C B. Mahoney
Heparin-bonded circuits: clinical outcomes and costs
Perfusion, May 1, 1998; 13(3): 192 - 204.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. L. Lazar, X. Zhang, T. Hamasaki, C. A. Memmelo, P. Treanor, S. Rivers, G. S. Aldea, S. A. Bernard, and R. J. Shemin
Heparin-Bonded Circuits Decrease Myocardial Ischemic Damage: An Experimental Study
Ann. Thorac. Surg., June 1, 1997; 63(6): 1701 - 1705.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
E. M. Boyle Jr, T. H. Pohlman, M. C. Johnson, and E. D. Verrier
Endothelial Cell Injury in Cardiovascular Surgery: The Systemic Inflammatory Response
Ann. Thorac. Surg., January 1, 1997; 63(1): 277 - 284.
[Abstract] [Full Text]

Home page
 PerfusionHome page
S. Daniel
Review on the multifactorial aspects of bioincompatibility in CPB
Perfusion, May 1, 1996; 11(3): 246 - 255.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.